Pitfalls of patenting and state authorization of medicines
During the lifecycle of a medicine - from its development to consumption - the developer has to go through several stages, such as obtaining the exclusive right for a medicine, obtaining permission to produce the medicine, obtaining permission to distribute and use the medicine, i.e. the developer h...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2018-02-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/64 |
| _version_ | 1826566772697858048 |
|---|---|
| author | V. I. Semenov E. B. Gavrilova N. B. Lyskov |
| author_facet | V. I. Semenov E. B. Gavrilova N. B. Lyskov |
| author_sort | V. I. Semenov |
| collection | DOAJ |
| description | During the lifecycle of a medicine - from its development to consumption - the developer has to go through several stages, such as obtaining the exclusive right for a medicine, obtaining permission to produce the medicine, obtaining permission to distribute and use the medicine, i.e. the developer has to patent and register the invention and obtain a marketing authorization for it. In order to accomplish these procedures that fall within the remit of the Federal Service for Intellectual Property and the Ministry of Health of Russia, developers have to submit documents described in relevant legislative acts. The article describes the patenting procedure used by the Federal Service for Intellectual Property, including examination as to form and substantive examination. It also addresses some problems associated with patenting medicines and their state authorization. A conclusion is drawn on the importance of searching for unexpired patents and their analysis in order to prevent situations in which developers of medicines infringe the rights of others. |
| first_indexed | 2024-03-07T19:18:10Z |
| format | Article |
| id | doaj.art-80d991c59aaa48069ee0fa556dc291a7 |
| institution | Directory Open Access Journal |
| issn | 3034-3062 3034-3453 |
| language | Russian |
| last_indexed | 2025-03-14T10:56:58Z |
| publishDate | 2018-02-01 |
| publisher | Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) |
| record_format | Article |
| series | Регуляторные исследования и экспертиза лекарственных средств |
| spelling | doaj.art-80d991c59aaa48069ee0fa556dc291a72025-03-02T10:46:39ZrusFederal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)Регуляторные исследования и экспертиза лекарственных средств3034-30623034-34532018-02-0104434662Pitfalls of patenting and state authorization of medicinesV. I. Semenov0E. B. Gavrilova1N. B. Lyskov2Federal State Budgetary Institution «Federal Institution of Industrial Property» of Federal Service for Intellectual PropertyFederal State Budgetary Institution «Federal Institution of Industrial Property» of Federal Service for Intellectual PropertyFederal State Budgetary Institution «Federal Institution of Industrial Property» of Federal Service for Intellectual PropertyDuring the lifecycle of a medicine - from its development to consumption - the developer has to go through several stages, such as obtaining the exclusive right for a medicine, obtaining permission to produce the medicine, obtaining permission to distribute and use the medicine, i.e. the developer has to patent and register the invention and obtain a marketing authorization for it. In order to accomplish these procedures that fall within the remit of the Federal Service for Intellectual Property and the Ministry of Health of Russia, developers have to submit documents described in relevant legislative acts. The article describes the patenting procedure used by the Federal Service for Intellectual Property, including examination as to form and substantive examination. It also addresses some problems associated with patenting medicines and their state authorization. A conclusion is drawn on the importance of searching for unexpired patents and their analysis in order to prevent situations in which developers of medicines infringe the rights of others.https://www.vedomostincesmp.ru/jour/article/view/64medicinepatentmarketing authorizationлекарственное средствопатентрегистрационное удостоверение |
| spellingShingle | V. I. Semenov E. B. Gavrilova N. B. Lyskov Pitfalls of patenting and state authorization of medicines Регуляторные исследования и экспертиза лекарственных средств medicine patent marketing authorization лекарственное средство патент регистрационное удостоверение |
| title | Pitfalls of patenting and state authorization of medicines |
| title_full | Pitfalls of patenting and state authorization of medicines |
| title_fullStr | Pitfalls of patenting and state authorization of medicines |
| title_full_unstemmed | Pitfalls of patenting and state authorization of medicines |
| title_short | Pitfalls of patenting and state authorization of medicines |
| title_sort | pitfalls of patenting and state authorization of medicines |
| topic | medicine patent marketing authorization лекарственное средство патент регистрационное удостоверение |
| url | https://www.vedomostincesmp.ru/jour/article/view/64 |
| work_keys_str_mv | AT visemenov pitfallsofpatentingandstateauthorizationofmedicines AT ebgavrilova pitfallsofpatentingandstateauthorizationofmedicines AT nblyskov pitfallsofpatentingandstateauthorizationofmedicines |